Safety of Continuing CHemotherapy in Overt Left Ventricular Dysfunction Using Antibodies to HER-2
Clinical trial NCT02907021 · COMPLETED
Trial details
- NCT number
- NCT02907021
- Sponsor
- Population Health Research Institute
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-11-01
- Primary completion
- 2018-04-12
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.